Combination therapy in the management of hypertension: focus on angiotensin receptor blockers combined with diuretics.
There is increasing evidence that combination therapy should be emphasized more than it is at present for the initial treatment of hypertensive patients. Recent guidelines acknowledge the value of combination therapy, although some treatment algorithms fail to echo this message. Observations from major clinical trials in the elderly, diabetics, stroke patients, and African Americans all indicate that combination therapy is necessary to control blood pressure in the majority of these patients. Several combination therapies such as an angiotensin II receptor blocker and a diuretic, an angiotensin-converting enzyme inhibitor with a diuretic, a beta blocker with a diuretic, or an angiotensin-converting enzyme inhibitor with a calcium antagonist have been shown to be effective in patients who do not respond to monotherapy. The current review focuses on the newest such combination; an angiotensin II receptor blocker and a diuretic may have an added advantage of being well tolerated. Recent studies have shown that angiotensin II receptor blockers, given alone or combined with a diuretic, may prevent some cardiovascular outcomes independent of their blood pressure-lowering efficacy.
Palatini
Paolo
P
University of Padova, Padova, Italy. palatini@unipd.it
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D001581:Benzothiadiazines; D004232:Diuretics; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use*
D047228:Angiotensin II Type 1 Receptor Blockers; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors
J Hum Hypertens. 2000 Apr;14(4):263-9
10805052
Clin Ther. 1995 Sep-Oct;17(5):911-23
8595643
N Engl J Med. 2003 Feb 13;348(7):583-92
12584366
Clin Ther. 2004 Jun;26(6):855-65
15262456
Blood Press Suppl. 2003 Dec;2:41-7
14761076
JAMA. 1967 Dec 11;202(11):1028-34
4862069
Hypertension. 2001 Jan;37(1):12-18
11208750
Clin Ther. 2002 Jul;24(7):1049-61
12182251
JAMA. 2003 Dec 3;290(21):2805-16
14657064
Lancet. 2001 Sep 29;358(9287):1033-41
11589932
Lancet. 1998 Jun 13;351(9118):1755-62
9635947
Blood Press Suppl. 2003 May;1:36-43
12800986
Lancet. 2002 Mar 23;359(9311):995-1003
11937178
J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1):9-13
12556647
JAMA. 2003 Jul 9;290(2):199-206
12851274
Clin Ther. 2001 Aug;23(8):1193-208
11558858
N Engl J Med. 2001 Sep 20;345(12):870-8
11565519
J Hum Hypertens. 1998 Oct;12(10):693-9
9819017
JAMA. 2002 Dec 18;288(23):2981-97
12479763
Lancet. 2004 Jun 19;363(9426):2022-31
15207952
N Engl J Med. 2001 Sep 20;345(12):861-9
11565518
Adv Ther. 2004 Mar-Apr;21(2):107-22
15310084
Am Fam Physician. 1997 Oct 1;56(5):1275-6, 1279, 1282
9337752
JAMA. 2003 May 21;289(19):2560-72
12748199
Am J Cardiol. 2001 Mar 15;87(6):721-6
11249890
J Hypertens. 2003 Jun;21(6):1011-53
12777938
Cardiol Clin. 2002 May;20(2):181-5, v
12119794
Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):973-85
10423118
Clin Ther. 2003 Nov;25(11):2765-80
14693303
Med J Aust. 2003 Sep 15;179(6):306-12
12964914
J Hypertens. 2000 Mar;18(3):327-37
10726720
J Hypertens. 2003 May;21(5):875-86
12714861
Expert Rev Cardiovasc Ther. 2003 May;1(1):43-50
15030296
Clin Ther. 2003 May;25(5):1469-89
12867222
BMJ. 1998 Sep 12;317(7160):703-13
9732337